Skip to main content
. 2022 Mar 30;22:313. doi: 10.1186/s12879-022-07289-3

Table 3.

Incidence rates of virus-specific LRTIs per 100 child-years and IRRs for severe LRTI compared to non-severe LRTI in Biliran, Philippines, from March 2014 to June 2016

Detected virus LRTI classification 0–5 months 6–11 months 12–23 months
n IR [95%CI] IRR [95%CI] n IR [95%CI] IRR [95%CI] n IR [95%CI] IRR [95%CI]
AdV Non-severe 0 0.0 [0.0–2.1] 1 2 1.4 [0.2–5.0] 1 1 0.7 [0.0–3.7] 1
Severe 0 0.0 [0.0–2.1] 0.00 [0.00–0.00] 0 0.0 [0.0–2.5] 0.00 [0.00–5.32] 0 0.0 [0.0–2.4] 0.00 [0.00–39.00]
Total 0 0.0 [0.0–2.1] 2 1.4 [0.2–5.0] 1 0.7 [0.0–3.7]
RV Non-severe 24 13.7 [8.8–20.4] 1 13 8.9 [4.8–15.3] 1 22 14.5 [9.1–21.9] 1
Severe 15 8.6 [4.8–14.1] 0.63 [0.30–1.24] 7 4.8 [1.9–9.9] 0.54 [0.18–1.45] 4 2.6 [0.7–6.7] 0.18 [0.05–0.54]
Total 39 22.3 [15.8–30.4] 21 14.4 [8.9–22.0] - - 27 17.7 [11.7–25.8]
EV Non-severe 1 0.6 [0.0–3.2] 1 2 1.4 [0.2–5.0] 1 3 2.0 [0.4–5.8] 1
Severe 2 1.1 [0.1–4.1] 2.00 [0.10–117.99] 1 0.7 [0.0–0.0] 0.50 [0.01–9.60] 1 0.7 [0.0–3.7] 0.33 [0.01–4.15]
Total 3 1.7 [0.4–5.0] 3 2.1 [0.4–6.0] - - 4 2.6 [0.7–6.7]
RSV Non-severe 15 8.6 [4.8–14.1] 1 3 2.1 [0.4–6.0] 1 12 7.9 [4.1–13.8] 1
Severe 11 6.3 [3.1–11.2] 0.73 [0.30–1.71] 7 4.8 [1.9–9.9] 2.33 [0.53–13.98] 5 3.3 [1.1–7.7] 0.42 [0.11–1.27]
Total 27 15.4 [10.2–22.4] 11 7.6 [3.8–13.5] 18 11.8 [7.0–18.7]
MPV Non-severe 1 0.6 [0.0–3.2] 1 1 0.7 [0.0–3.8] 1 4 2.6 [0.7–6.7] 1
Severe 1 0.6 [0.0–3.2] 1.00 [0.01–78.50] 0 0.0 [0.0–2.5] 0.00 [0.00–39.00] 2 1.3 [0.2–4.7] 0.50 [0.05–3.49]
Total 2 1.1 [0.1–4.1] 1 0.7 [0.0–3.8] 6 3.9 [1.5–8.6]
PIV Non-severe 4 2.3 [0.6–5.8] 1 7 4.8 [1.9–9.9] 1 11 7.2 [3.6–12.9] 1
Severe 2 1.1 [0.1–4.1] 0.50 [0.05–3.49] 4 2.7 [0.7–7.0] 0.57 [0.12–2.25] 0 0.0 [0.0–2.4] 0.00 [0.00–0.40]
Total 6 3.4 [1.37.5] 11 7.6 [3.8–13.5] 11 7.2 [3.6–12.9]
IFV Non-severe 3 1.7 [0.4–5.0] 1 4 2.7 [0.7–7.0] 1 4 2.6 [0.7–6.7] 1
Severe 1 0.6 [0.0–3.2] 0.33 [0.01–4.15] 3 2.1 [0.4–6.0] 0.75 [0.11–4.43] 3 2.0 [0.4–5.8] 0.75 [0.11–4.43]
Total 5 2.9 [0.9–6.7] 7 4.8 [1.9–9.9] 7 4.6 [1.9–9.5]
Co-detection Non-severe 7 4.0 [1.6–8.2] 1 3 2.1 [0.4–6.0] 1 1 0.7 [0.0–3.7] 1
Severe 2 1.1 [0.1–4.1] 0.29 [0.03–1.50] 1 0.7 [0.0–3.8] 0.33 [0.01–4.15] 1 0.7 [0.0–3.7] 1.00 [0.01–78.50]
Total 9 5.1 [2.4–9.8] 4 2.7 [0.8–7.0] 3 2.0 [0.4–5.8]
Negative Non-severe 20 11.4 [7.0–17.6] 1 20 13.7 [8.4–21.2] 1 28 18.4 [12.2–26.6] 1
Severe 11 6.3 [3.1–11.2] 0.55 [0.24–1.20] 13 8.9 [4.8–15.3] 0.65 [0.30–1.37] 7 4.6 [1.8–9.5] 0.25 [0.09–0.59]
Total 31 17.7 [12.0–25.1] 34 23.3 [16.2–32.6] 36 23.7 [16.6–32.8]
Total Non-severe 75 42.8 [33.7–53.7] 1 55 37.8 [28.4–49.1] 1 86 56.5 [45.2–69.8] 1
Severe 45 25.7 [18.7–34.4] 0.61 [0.41–0.88] 36 24.7 [17.3–34.2] 0.65 [0.42–1.01] 23 15.1 [9.6–22.7] 0.27 [0.16–0.43]
Total 122 69.6 [57.8–83.2] 94 64.5 [52.1–79.0] 113 74.3 [61.2–89.3]

Total LTRTI included non-severe LRTI, severe LRTI and undefined LRTI. Observed child-years were 175.2, 145.7, and 152.2 at age 0–5, 6–11, and 12–23 months, respectively. Episodes in which samples were not tested for virus detection were excluded (n = 21)

IR, incidence rate; IRR, incidence rate ratio; LRTI, lower respiratory tract infection; 95%CI, 95% confidence interval; AdV, Adenovirus; RV, Rhinovirus; EV, Enterovirus; RSV, Respiratory syncytial virus; MPV, Human metapneumovirus; PIV, Parainfluenza virus; IFV, Influenza virus